Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT06359821
What this trial is testing

Evaluate Safety, Whole-Body Distribution and Radiation Dosimetry in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sichuan University 4
Early research (Phase 1)Looking for participantsNCT03460977
What this trial is testing

Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)Small Cell Lung Cancer (SCLC)Follicular Lymphoma (FL)
Pfizer 453
Testing effectiveness (Phase 2)Looking for participantsNCT07408063
What this trial is testing

A Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05081609
What this trial is testing

Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Advanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+10 more
Ascendis Pharma Oncology Division A/S 320
Testing effectiveness (Phase 2)Study completedNCT00117299
What this trial is testing

PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib

Who this might be right for
Sarcoma
University of Helsinki 45
Not applicableStudy completedNCT03097601
What this trial is testing

ELR+CXCL Cytokines in Metastatic Kidney Cancers: Predictive Markers of Resistance to Sunitinib

Who this might be right for
Metastatic Kidney Cancers
Centre Antoine Lacassagne 60
Testing effectiveness (Phase 2)Looking for participantsNCT06533644
What this trial is testing

SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Syncromune, Inc. 91
Early research (Phase 1)Looking for participantsNCT07029399
What this trial is testing

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
HR+ Breast CancerTriple Negative Breast Cancer (TNBC)CCNE1 Amplified Advanced Solid Tumors+1 more
NiKang Therapeutics, Inc. 361
Testing effectiveness (Phase 2)Ended earlyNCT01488318
What this trial is testing

Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma Of The Head And Neck
Julie E. Bauman, MD, MPH 21
Large-scale testing (Phase 3)Study completedNCT01810770
What this trial is testing

Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis

Who this might be right for
Prostatic Neoplasms
Bayer 243
Testing effectiveness (Phase 2)Study completedNCT01120470
What this trial is testing

OGX-427 in Castration Resistant Prostate Cancer Patients

Who this might be right for
Castration Resistant Prostate Cancer
British Columbia Cancer Agency 74
Large-scale testing (Phase 3)Ended earlyNCT01313273
What this trial is testing

Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Ipsen 3
Not applicableStudy completedNCT00900380
What this trial is testing

Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
ECOG-ACRIN Cancer Research Group 40
Testing effectiveness (Phase 2)Study completedNCT01472770
What this trial is testing

A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Vejle Hospital 49
Not applicableNo Longer AvailableNCT01516762
What this trial is testing

Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Who this might be right for
Prostatic Neoplasms
Bayer
Testing effectiveness (Phase 2)Active Not RecruitingNCT04253262
What this trial is testing

Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Brown University 13
Testing effectiveness (Phase 2)Ended earlyNCT03752099
What this trial is testing

To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Veru Inc. 80
Testing effectiveness (Phase 2)Looking for participantsNCT03591276
What this trial is testing

Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Shaare Zedek Medical Center 15
Large-scale testing (Phase 3)Study completedNCT01057810
What this trial is testing

Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 837
Testing effectiveness (Phase 2)Looking for participantsNCT04104776
What this trial is testing

Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Who this might be right for
Advanced Solid TumorDiffuse Large B Cell LymphomaLymphoma, T-Cell+5 more
Novartis Pharmaceuticals 300
Next Page